Smolka Vratislav, Ehrmann Jiří, Tkachyk Oksana, Zápalka Martin
Cas Lek Cesk. 2014;153(2):91-7.
In recent years, nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) in children have increased in line with the increased prevalence of obesity. The aim of this retrospective study was to evaluate a relation between NAFDL and MS in children.
NAFLD was defined as an elevation of serum transaminase level and hyperechogenic feature of liver on ultrasonography. MS definition was based on the diagnostic criteria of the International Diabetes Federation. The biopsies were done in patients with elevated transaminase levels lasting more than one year. Liver biopsy features were graded according to the NAFLD activity scoring (NAS) and Paediatric NAFLD Histological Score (PNHS).
NAFLD was diagnosed in 39 patients and MS was confirmed in 20 patients. The significant differences between patients with MS and without MS were found in the insulin resistance (IR) (P < 0,001), cholesterol levels (P < 0,04) and GGT levels (P < 0,05). Biopsies were done in 20 patients. MS was present in 10 children. No difference was found in the degree of steatosis and NAS in groups with and without MS. No differences were observed in the occurrence of MS diagnostic criteria between patients with and without nonalcoholic steatohepatitis which were evaluated by PNHS.
Prediction factors for NAFLD are obesity, IR, dyslipidemia. NAFLD is frequently associated with MS. Liver biopsy is necessary for determination of NAFLD histological activity because no non-invasive examination defines the degree of liver pathology.
近年来,儿童非酒精性脂肪性肝病(NAFLD)和代谢综合征(MS)的发病率随着肥胖患病率的增加而上升。本回顾性研究的目的是评估儿童NAFLD与MS之间的关系。
NAFLD定义为血清转氨酶水平升高及肝脏超声检查显示高回声特征。MS的定义基于国际糖尿病联盟的诊断标准。对转氨酶水平升高持续超过一年的患者进行活检。肝活检特征根据NAFLD活动评分(NAS)和儿童NAFLD组织学评分(PNHS)进行分级。
39例患者被诊断为NAFLD,20例患者确诊为MS。MS患者与非MS患者在胰岛素抵抗(IR)(P < 0.001)、胆固醇水平(P < 0.04)和γ-谷氨酰转移酶水平(P < 0.05)方面存在显著差异。对20例患者进行了活检。10名儿童患有MS。有MS和无MS的组在脂肪变性程度和NAS方面未发现差异。通过PNHS评估,非酒精性脂肪性肝炎患者和非患者在MS诊断标准的发生率上未观察到差异。
NAFLD的预测因素为肥胖、IR、血脂异常。NAFLD常与MS相关。由于没有非侵入性检查能确定肝脏病理程度,因此肝活检对于确定NAFLD组织学活性是必要的。